Surrozen, Inc./DE(SRZN)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Surrozen, Inc./DE (SRZN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SRZN at 18.1/100 on a 32-signal composite quality model, placing it at rank #2,812 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Surrozen, Inc./DE reports quarterly revenue of $5.0M, net income of $50.2M, free cash flow of $-7.4M. Top institutional holders of SRZN by reported 13-F value include Column Group, TCG Crossover Management, Boxer Capital Management, based on the most recent SEC filings. SRZN trades on the Nasdaq exchange and files with the SEC under CIK 1824893. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SRZN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Surrozen, Inc./DE directly from SEC EDGAR.

AI Quality Score

18.1/100

AI Rank

#2,812

Revenue

$5.0M

Net Income

$50.2M

Free Cash Flow

$-7.4M

SRZN key financials by period

Surrozen, Inc./DE reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$3.5M$-242.0M
FY 202410-K$10.7M$-63.6M
FY 202210-K$12.5M$-36.0M

Institutions holding SRZN

Institutional investors reporting a position in Surrozen, Inc./DE on SEC Form 13F.
InstitutionSharesValueReported
Column Group1,916,950$49.7M2026-06-30
TCG Crossover Management1,473,101$38.2M2026-06-30
Boxer Capital Management1,105,683$27.0M2026-06-30
MILLENNIUM MANAGEMENT683,079$17.7M2026-06-30
Point72 Asset Management, L.P.664,272$17.2M2026-06-30
VR Adviser632,931$16.4M2026-06-30
StemPoint Capital602,798$13.8M2026-06-30
PERCEPTIVE ADVISORS503,985$13.1M2026-06-30
Spruce Street Capital432,040$11.2M2026-06-30
BlackRock394,864$10.2M2026-06-30
SRZN

Surrozen, Inc./DE

SRZN
NasdaqSmall CapHealthcare

13F Pro Quality Score

18.1/100

Rank #2,812 of 2,961 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$5.00M

Net Income

Q2 2026
EDGAR

$50.18M

EPS (Diluted)

Q2 2026
EDGAR

$-0.41

Free Cash Flow

Q2 2026
EDGAR

$-7.43M

Top Institutional Holders

as of Q2 2026
$319.42M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…